| Literature DB >> 28404596 |
Margaret Chui Ling Tse1, Oana Herlea-Pana2, Daniel Brobst2, Xiuying Yang2,3, John Wood2, Xiang Hu2, Zhixue Liu2, Chi Wai Lee1, Aung Moe Zaw4, Billy K C Chow4, Keqiang Ye5, Chi Bun Chan6.
Abstract
Tumor necrosis factor-α (TNF-α) is an inflammatory cytokine that plays a central role in obesity-induced insulin resistance. It also controls cellular lipid metabolism, but the underlining mechanism is poorly understood. We report in this study that phosphoinositide 3-kinase enhancer A (PIKE-A) is a novel effector of TNF-α to facilitate its metabolic modulation in the skeletal muscle. Depletion of PIKE-A in C2C12 myotubes diminished the inhibitory activities of TNF-α on mitochondrial respiration and lipid oxidation, whereas PIKE-A overexpression exacerbated these cellular responses. We also found that TNF-α promoted the interaction between PIKE-A and AMP-activated protein kinase (AMPK) to suppress its kinase activity in vitro and in vivo. As a result, animals with PIKE ablation in the skeletal muscle per se display an upregulation of AMPK phosphorylation and a higher preference to use lipid as the energy production substrate under high-fat diet feeding, which mitigates the development of diet-induced hyperlipidemia, ectopic lipid accumulation, and muscle insulin resistance. Hence, our data reveal PIKE-A as a new signaling factor that is important for TNF-α-initiated metabolic changes in skeletal muscle.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28404596 PMCID: PMC5482076 DOI: 10.2337/db16-0270
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461